Last reviewed · How we verify
NCT07590882
Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study
trial testing Correction Factor in Hip Surgeries in 26 participants. Enrolling by invitation.
Quick facts
| Lead sponsor | Istituto Ortopedico Rizzoli |
|---|---|
| Status | ENROLLING BY INVITATION |
| Enrollment | 26 |
| Start date | 4 November 2025 |
| Estimated completion | 1 January 2027 |
Drugs / interventions tested
- Correction Factor — full drug profile →
Conditions studied
- Hip Surgeries — all drugs for Hip Surgeries →
- Hip Developmental Dysplasia — all drugs for Hip Developmental Dysplasia →
Sponsor
Istituto Ortopedico Rizzoli — full company profile →
Who can join
Eligibility, any sex, with Hip Surgeries or Hip Developmental Dysplasia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07590882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Istituto Ortopedico Rizzoli trials
Trials by the same sponsor.
- NCT07021222 — Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaF · NA · recruiting
- NCT07360964 — Clear Cell Chondrosarcoma in Italy · NA · active not recruiting
- NCT07140367 — "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology" · recruiting
- NCT07102875 — Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases · NA · active not recruiting
- NCT07311187 — Quiet Quitting, Quality of Life, and Coping Strategies Among Healthcare Workers · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07590882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Ortopedico Rizzoli
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07590882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing